Moderna
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Moderna generated cash of -$3,118,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,377,000,000 last year. Net change in cash is therefore -$289,000,000.
Cash Flow
| 2016 | 66.73M | -648.60M | 472.91M |
|---|---|---|---|
| 2017 | -331.48M | 416.09M | 168K |
| 2018 | -330.86M | -372.47M | 1.22B |
| 2019 | -458.96M | -14.94M | 51.12M |
| 2020 | 2.02B | -1.67B | 2.03B |
| 2021 | 13.62B | -8.52B | -873M |
| 2022 | 4.98B | -5.17B | -3.44B |
| 2023 | -3.11B | 4.20B | -1.37B |
MRNA Cash Flow Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.21B | 6.86B | 2.63B | 247.69M | 670.49M | 134.85M | 50.08M | 159.04M |
Operating activities | ||||||||
Net income | -4.71B | 8.36B | 12.20B | -747.06M | -514.02M | -384.73M | -255.91M | -216.21M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||
Depreciation and amortization | 621M | 348M | 232M | 31.25M | 31.02M | 24.86M | 20.53M | 15.11M |
Stock-based compensation expense | 305M | 226M | 142M | 93M | 81.12M | 0 | 40.05M | 39.36M |
| Deferred income tax benefit | 305M | 226M | 142M | 93M | 81.12M | 0 | 40.05M | 39.36M |
| Changes in operating assets and liabilities: | ||||||||
Accounts receivable, net | 493M | 1.79B | -1.78B | -1.38B | 7.21M | 832K | 106K | 52.33M |
Inventories | 747M | 492M | -1.39B | -46.52M | 7.20M | 4.40M | 34.80M | -582K |
Accounts payable | 13M | 240M | 204M | 11.87M | -23.96M | 15.01M | -12.76M | 5.99M |
Cash generated by operating activities | -3.11B | 4.98B | 13.62B | 2.02B | -458.96M | -330.86M | -331.48M | 66.73M |
Investing activities | ||||||||
Purchases Of Investments | -3.76B | -11.43B | -12.65B | -2.95B | -1.14B | -1.22B | -727.20M | -1.41B |
Investments In Property Plant And Equipment | -707M | -400M | -284M | -67.44M | -31.55M | -105.76M | -58.40M | -33.14M |
Acquisitions Net | -85M | 0 | 0 | 1.60B | -17M | 0 | 0 | 0 |
Cash generated by investing activities | 4.20B | -5.17B | -8.52B | -1.67B | -14.94M | -372.47M | 416.09M | -648.60M |
Financing activities | ||||||||
Common Stock Issued | 46M | 65M | 124M | 1.85B | 47.25M | 563.02M | 212K | 473.54M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -1.48M | 0 |
Repurchases of common stock | -1.15B | -3.32B | -857M | 7.04M | 2.89M | -8.18M | 0 | 0 |
Repayments of term debt | -270M | -184M | -140M | -6.21M | 1M | -2.17M | 1.43M | 0 |
Cash used in financing activities | -1.37B | -3.44B | -873M | 2.03B | 51.12M | 1.22B | 168K | 472.91M |
Net Change In Cash | -289M | -3.64B | 4.22B | 2.38B | -422.79M | 523.50M | 84.77M | -108.96M |
Cash at end of period | 2.92B | 3.21B | 6.86B | 2.63B | 247.69M | 658.36M | 134.85M | 50.08M |
| Data source | Data source | Data source | Data source | Data source | Data source |